ArticleJournal of cancer research and clinical oncology2023

The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.

Yanxia He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.